About Zorbium™
The only FDA-approved long-acting transdermal buprenorphine for cats
- Indicated for the control of postoperative pain associated with surgical procedures in cats
- Pre-dosed tubes for smaller and larger cats simplifies record-keeping and disposal of controlled substances
Delivers 4 days of reliable pain relief from a single, in-clinic dose
- Rapidly dries after topical application, forming a depot within the skin that releases buprenorphine continuously into systemic circulation
- Avoids the peaks and valleys in plasma drug concentrations and potential for missed doses associated with repeat dosing protocols
Providing reassurance to veterinarians and pet owners
- Administered once in clinic, Zorbium removes the need to administer repeat injections or dispense buprenorphine during the critical first few days after surgery
- Reduces the challenges of administering pain medications at home and helps limit the risk of opioid misuse by pet owners
How does Zorbium™ work?
One in-clinic dose of Zorbium™ provides 4 days of continuous post-op pain control for at-home comfort.
Designed for in-clinic efficiency and extends your care to home
Features and benefits
- Delivers 4 days of reliable pain relief from a single, topical dose
- Gradually releases buprenorphine into systemic circulation, avoiding the peaks and valleys in plasma blood concentrations and potential for missed doses associated with repeat dosing protocols
- Removes the need to administer repeat injections or dispense buprenorphine during the critical first few days after surgery
- Administered in clinic, Zorbium keeps you in control of opioid analgesia
- No need to dispense buprenorphine
- Limits risk of opioid misuse by pet owners
- Reduces challenges of administering pain medications at home
- Provides reassurance that your patients have pain relief on board
